Klyv Therapeutics Revenue
Biotechnology Research • 
Oslo, Oslo, Norway • 1-10 Employees
$
Klyv Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Klyv Therapeutics
Maria Vistnes
Chief Executive Officer
Company overview
| Headquarters | Gaustadalléen 21, Oslo, 0349, NO |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
About Klyv Therapeutics
Developing anti-fibrotic therapies for the use in heart failure and other fibrotic diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Klyv Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Klyv Therapeutics has never raised funding before.
Singapore
United States
United Kingdom
United Arab Emirates
Colombia
Frequently asked questions
Klyv Therapeutics is located in Oslo, Oslo, NO.
Klyv Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
Klyv Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Klyv Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
Klyv Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
